Learn More
Medchemexpress LLC Teneligliptin hydrobromide | 906093-29-6 | MFCD20279612 | ≥98.0% | 628.86 | 25 MG

Supplier: Medchemexpress LLC 25MGHY14806A
Teneligliptin hydrobromide is an orally active, potent, and highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor. It improves blood glucose levels and is utilized in research related to type 2 diabetes mellitus. The compound exhibits a unique 'J-shaped' structure, enabling it to bind to four subsites of DPP-4.
- Orally active and selective dipeptidyl peptidase-4 (DPP-4) inhibitor.
- Improves blood glucose levels.
- Used in research for type 2 diabetes mellitus.
- Exhibits a unique 'J-shaped' structure for effective DPP-4 binding.
- Prevents activation of the NLRP3 inflammasome and injury by increasing AMPK phosphorylation.
- Protects against hypoxia/reoxygenation-induced endothelial cell injury.
- Inhibits lipopolysaccharide-induced cytotoxicity and inflammation.
- Prevents high glucose and H2O2 induced USP22-SIRT1 downregulation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.